Cannabis Scientists

This list of the world’s top cannabis scientists was inspired by the passing of Raphael Mechoulam, who undoubtedly influenced every cannabis scientist detailed here. Supporting those who work in the science of cannabis is critical to overturning decades of stigma, pushing regulators to adopt cannabis science, and helping people understand the therapeutic and medical value of cannabinoids and other phytochemicals found in cannabis.

The cannabis scientists and researchers listed here are in random order, and, if readers want to add to this list, they can do so using our CONTACT PAGE.  

Austin Sheppe, Ph.D.

*Ph.D. in Microbiology and Cell Science from the University of Florida

*Cannabis Genomics and Breeding


Yersinia pseudotuberculosis YopJ Limits Macrophage Response by Downregulating COX-2-Mediated Biosynthesis of PGE2 in a MAPK/ERK-Dependent Manner

Roles of Eicosanoids in Regulating Inflammation and Neutrophil Migration as an Innate Host Response to Bacterial Infections

Antigen-encapsulating host extracellular vesicles derived from Salmonella-infected cells stimulate pathogen-specific Th1-type responses in vivo

Exosomes released by breast cancer cells under mild hyperthermic stress possess immunogenic potential and modulate polarization in vitro in macrophages

PGE2 Augments Inflammasome Activation and M1 Polarization in Macrophages Infected With Salmonella Typhimurium and Yersinia enterocolitica

tRNA-dependent alanylation of diacylglycerol and phosphatidylglycerol in Corynebacterium glutamicum.

Ethan Russo, M.D.

*M.D. from UMass Chan Medical School

*Certified Neurologist by American Board of Psychiatry and Neurology

*Cannabis entourage researcher, child neurology specialist, formerly of GW Pharmaceuticals, now CReDO Science


Even high doses of oral cannabidiol do not cause THC-like effects in humans.

Beyond cannabis: Plants and the endocannabinoid system

Cannabidiol claims and misconceptions

Clinical endocannabinoid deficiency reconsidered: Current research support the theory in migraine, fibromyalgia, irritable bower, and other treatment-resistant syndromes.

Current therapeutic cannabis controversies and clinical trial design issues.

The Cannabis sativa versus Cannabis indica debate: An interview with Ethan Russo, MD

Current status and future of cannabis research

Synthetic and natural cannabinoids: The cardiovascular risk.

Cannabis Inflorescence: Standards of Identity, Analysis and Quality Control

Taming THC: potential cannabis synergy and phytocannabinoid-terpenoid entourage effects.

A randomized, double-blind, placebo-controlled, crossover study to evaluate the subjective abuse potential and cognitive effects of nabiximols oromucosal spray in subjects with a history of recreational cannabis use

Jill Carreiro

*BS, Bioengineering, Arizona State University

*Cannabis Analytical Testing, Orange Photonics

Mark Scialdone, Ph.D.

*Ph.D. in Chemistry from Wayne State University

*Cannabis Chemist

*Long time research scientist for DuPont


Hydrogenation of Naturally-Derived Nepetalactone as a Topical Insect Repellent

The Identification of Δ-8 Tetrahydrocannabinolic Acid (Δ-8-THCA) by NMR and LCMS Techniques

Hydrogenated Cannabis Oil

Lysinol: A Renewably Resourced Alternative to Petrochemical Polyamines and Aminoalcohols

Dihydronepetalactones Deter Feeding Activity by Mosquitoes, Stable Flies, and Deer Ticks

Repellency of Hydrogenated Catmint Oil Formulations to Black Flies and Mosquitoes in the Field.

Antimicrobial β-peptoids by a Block Synthesis Approach

Trans- Cyclopropyl β-Amino Acid Derivatives via Asymmetric Cyclopropanation Using A (Salen) Ru (II)- Catalyst

Resin-to-Resin Acyl and Aminoacyl Transfer Reactions Using Oxime Supports

Solid-phase Synthesis of Linear and Cyclic Amino Acid-Derived Urea Peptidomimetics

A New Resin for the Solid-Phase Synthesis of Ureas via Thermolytic Cleavage of Oxime-Carbamates

Octafunctionalized Polyhedral Oligosilsesquioxanes as Scaffolds: Synthesis of Peptidyl Silsesquioxanes

Diisocyanates as scaffolds for combinatorial libraries. The solid-phase synthesis of bis-ureas from polymer-supported diisocyanates

Shabnam Sarshar, Ph.D.

*Doctor of Pharmaceutical Biology and Phytochemistry from University of Munster

*Cannabis Phytochemical Researcher


Plants of the Gods and Their Recently Discovered Therapeutic Applications.

Traditionally used medicinal plants against uncomplicated urinary tract infections: Hexadecyl coumaric acid ester from the rhizomes of Agropyron repens (L.) P. Beauv. with antiadhesive activity against uropathogenic E. coli.

Steven Philpott

*Master of Science in Biological Sciences from Chicago State University

*Certified Professional Interpener

*Cannabis/Environmental Biology Researcher

Codi Peterson, PharmD

*Doctor of Pharmacy from Duquesne University

*Pediatric Pharmacist and cannabinologist

Shawna Vreeke, Ph.D.

*Ph.D. in Organic Chemistry from Portland State University

*Cannabis Toxicology and Risk Assessment


A First-Tier Framework for Assessing Toxicological Risk from Vaporized Cannabis Concentrates

A Simple Predictive Model for Estimating Relative E-cigarette Toxic Carbonyl Levels

Dihydroxyacetone levels in electronic cigarettes: Wick temperature and toxin formation.

E-cigarettes can emit formaldehyde at high levels under conditions that have been reported to be non-averse to users

Triacetin Enhances Levels of Acrolein, Formaldehyde Hemiacetals, and Acetaldehyde in Electronic Cigarette Aerosols

John MacKay, Ph.D.

*Ph.D. in Chemistry from the University of Vermont

*Cannabis Chemist, R&D

*Decades of cannabis research

Susan Trapp, Ph.D.

*Ph.D. in Biochemistry from the University of Maryland

*Cannabis Terpene Researcher


Genomic Organization of Plant Terpene Synthases and Molecular Evolutionary Implications

Defensive Resin Biosynthesis in Conifers

Draft genome sequence of Mentha longifolia and development of resources for mint cultivar improvement

Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma

Molecular signatures of neoadjuvant endocrine therapies for breast cancer: characteristics of response or intrinsic resistance, Breast Cancer Research and Treatment

Matthew Gates

*Cannabis IPM Researcher


Integrated Pest Management against Arthropod Pests of Cannabis sativa in the United States of America

Viral diseases of Hemp (Cannabis sativa)

Marijuana Garden Saver: A field guide to identifying and correcting cannabis problems

The Molecular Grammar of Plants and its Genetic Basis in Terpene Biosynthesis

Paul Muchowski, Ph.D.

*Ph.D. in Biological Structure from the University of Washington

*Cannabis neurodegenerative diseases scientist


Tryptophan 2,3-dioxygenase and indoleamine 2,3-dioxygenase 1 make separate, tissue-specific contributions to basal and inflammation-induced kynurenine pathway metabolism in mice

Targeted deletion of kynurenine 3-monooxygenase in mice: a new tool for studying kynurenine pathway metabolism in periphery and brain

Cannabinoid receptor 2 signaling in peripheral immune cells modulates disease onset and severity in mouse models of Huntington’s disease

Mutant huntingtin impairs immune cell migration in Huntington disease

Kynurenines in the mammalian brain: when physiology meets pathology.

Suppression of α-synuclein toxicity and vesicle trafficking defects by phosphorylation at S129 in yeast depends on genetic context

Bone marrow transplantation confers modest benefits in mouse models of Huntington’s disease

Kynurenine 3-Monooxygenase Inhibition in Blood Ameliorates Neurodegeneration

Hsp70 and Hsp40 functionally interact with soluble mutant huntingtin oligomers in a classic ATP-dependent reaction cycle

Mutant huntingtin fragments form oligomers in a polyglutamine length-dependent manner in vitro and in vivo

Monoclonal antibodies recognize distinct conformational epitopes formed by polyglutamine in a mutant huntingtin fragment.

Loss of Hsp70 exacerbates pathogenesis but not levels of fibrillar aggregates in a mouse model of Huntington’s disease.

A genomic screen in yeast implicates kynurenine 3-monooxygenase as a therapeutic target for Huntington disease

Modulation of neurodegeneration by molecular chaperones.

Hsp70 and Hsp40 attenuate formation of spherical and annular polyglutamine oligomers by partitioning monomer

Yeast genes that enhance the toxicity of a mutant huntingtin fragment or alpha-synuclein

Protein misfolding, amyloid formation, and neurodegeneration: a critical role for molecular chaperones?

Requirement of an intact microtubule cytoskeleton for aggregation and inclusion body formation by a mutant huntingtin fragment

Hsp70 and hsp40 chaperones can inhibit self-assembly of polyglutamine proteins into amyloid-like fibrils

Small heat-shock proteins and their potential role in human disease

ATP-enhanced molecular chaperone functions of the small heat shock protein human alphaB crystallin

Human alphaB-crystallin. Small heat shock protein and molecular chaperone

Dustin Sulak, Ph.D.

*Doctorate of Osteopathy from Arizona College of Osteopathic Medicine

*Medical Cannabis Doctor

*Specializes in treating refractory conditions with medical cannabis.


Current and Future Status of Cannabis Research.

A Survey on the Effect That Medical Cannabis Has on Prescription Opioid Medication Usage for the Treatment of Chronic Pain at Three Medical Cannabis Practice Sites

The current status of artisanal cannabis for the treatment of epilepsy in the United States.

Raising awareness: The implementation of medical cannabis and psychedelics used as an adjunct to standard therapy in the treatment of advanced metastatic breast cancer

Education, Knowledge, and Practice Characteristics of Cannabis Physicians: A Survey of the Society of Cannabis Clinicians.

Daniela Vergara, Ph.D.

*Ph.D. in Evolutionary Biology from Indiana University Bloomington

*Cannabis Researcher: Genomics, Breeding


Widely assumed phenotypic associations in Cannabis sativa lack a shared genetic basis

Anna Schwabe, Ph.D.

*Ph.D. in Biological Education from University of Northern Colorado

*Cannabis educator and R&D specialist

*Cannabis genetics expert


Comparative Genetic Structure of Cannabis sativa Including Federally Produced, Wild Collected, and Cultivated Samples

Genomic Evidence That Governmentally Produced Cannabis sativa Poorly Represents Genetic Variation Available in State Markets

Research grade marijuana supplied by the National Institute on Drug Abuse is genetically divergent from commercially available Cannabis

Genetic tools weed out misconceptions of strain reliability in Cannabis sativa: Implications for a budding industry

Weeding out the truth behind Cannabis strain names: Genetic analyses confirm strain names are inconsistent and need regulation

Bruce Bugbee, Ph.D.

*Ph.D. in Environmental Plant Physiology

*Professor of Plants, Soils, and Biometeorology at Utah State University

Matthew Indest, Ph.D.

*Ph.D. in Plant, Environmental, and Soil Sciences from Louisiana State University

*Technical Director of Agronomy and Plant Improvement at Curaleaf

Patrick Woods, Ph.D.

*Ph.D. in Plant Breeding, Genetics, and Genomics from Colorado State University

*Cannabis genetics, genomics, breeding expert


Genome-wide polymorphism and genic selection in feral and domesticated lineages of Cannabis sativa

Root Pulling Force Across Drought in Maize Reveals Genotype by Environment Interactions and Candidate Genes

Quantitative Trait Loci Controlling Agronomic and Biochemical Traits in Cannabis sativa

Jordi Petit Pedró, Ph.D.

*Ph.D. in Plant Breeding from Wageningen University & Research

*Cannabis geneticist

Christoper Grassa, Ph.D.

*Ph.D. in Domestication from Harvard University

*Cannabis genomics expert

Megan Mbengue

*Master of Science in Medical Cannabis Therapeutics from Pacific College

*Cannabis Nurse – CHPN, RN

Dylan Wilks

*Master of Science in Engineering Management from Tufts University

*Cannabis analytical testing expert


Challenges of an automated spectral responsivity characterization system

Lower Resolution Infrared (IR) Spectroscopy Can Provide Higher Performance for Quantitative Biodiesel Measurements

Synthetic Jet Fuel Blend Analysis using Mid-Infrared Spectroscopy

The impact of blending techniques, feedstock choice, and analytical techniques on biodiesel blend accuracy

Jeff Rawson, Ph.D.

*Ph.D. in Chemistry from Duke University

*Cannabis science advocate and researcher

Miyabe Shields, Ph.D.

*Ph.D. in Pharmaceutical Sciences from Northeastern University

*Endocannabinoid pharmacologist


Biochemical and Proteomic Characterization of Recombinant Human α/β Hydrolase Domain 6.

Synthesis and evaluation of potent and selective MGL inhibitors as a glaucoma treatment.

Anti-inflammatory effects of ω-3 polyunsaturated fatty acids and soluble epoxide hydrolase inhibitors in angiotensin-II-dependent hypertension.

Pharmacokinetics and in vivo potency of soluble epoxide hydrolase inhibitors in cynomolgus monkeys.

Allyn Howlett, Ph.D.

*Ph.D. in Biochemical Neuropharmacology from Rutgers University

*Professor at Wake Forest University Baptist Medical Center

*Discoverer of CB1 receptor for cannabinoid agonists


Increased Angiotensin II Contraction of the Uterine Artery at Early Gestation in a Transgenic Model of Hypertensive Pregnancy Is Reduced by Inhibition of Endocannabinoid Hydrolysis

Alterations in the Medullary Endocannabinoid System Contribute to Age-related Impairment of Baroreflex Sensitivity

Is there a role for anandamide in cardiovascular regulation? Insights from studies of endocannabinoid metabolism

Steric Trigger as a Mechanism for CB1 Cannabinoid Receptor Activation

Early phytocannabinoid chemistry to endocannabinoids and beyond

WIN55212-2 Docking to the CB1 Cannabinoid Receptor and Multiple Pathways for Conformational Induction

Endocannabinoid System in Pregnancy Maintenance and Labor: A Mini-Review

Endocannabinoids and Reactive Nitrogen and Oxygen Species in Neuropathologies

Cannabinoid Receptor Interacting Protein 1a (CRIP1a) in Health and Disease

Acute Depletion of D2 Receptors from the Rat Substantia Nigra Alters Dopamine Kinetics in the Dorsal Striatum and Drug Responsivity

The Spicy Story of Cannabimimetic Indoles

The Endocannabinoid System and Oligodendrocytes in Health and Disease

Cannabinoid Receptor Interacting Protein 1a (CRIP1a): Function and Structure

WIN55212-2 Modulates Intracellular Calcium via CB1 Receptor-Dependent and Independent Mechanisms in Neuroblastoma Cells

Cannabinoid receptor interacting protein 1a interacts with myristoylated Gαi N terminus via a unique gapped β-barrel structure

CB1 Cannabinoid Receptors Stimulate Gβγ-GRK2-Mediated FAK Phosphorylation at Tyrosine 925 to Regulate ERK Activation Involving Neuronal Focal Adhesions

Thyroid Effects on Adenosine 3′,5′-Monophosphate Levels and Adenylate Cyclase in Cultured Neuroblastoma Cells

Medullary Endocannabinoids Contribute to the Differential Resting Baroreflex Sensitivity in Rats with Altered Brain Renin-Angiotensin System Expression

Vincenzo di Marzo, Ph.D.

*Ph.D. in Biochemistry and Pharmacology from Imperial College London

*Canada Excellence Research Chair


The endocannabinoidome mediator N-oleoylglycine is a novel protective agent against 1-methyl-4-phenyl-pyridinium-induced neurotoxicity

New approaches and challenges to targeting the endocannabinoid system

Hemp seed significantly modulates the endocannabinoidome and produces beneficial metabolic effects with improved intestinal barrier function and decreased inflammation in mice under a high-fat, high-sucrose diet as compared with linseed

Positive association between plasmatic levels of orexin A and the endocannabinoid-derived 2-arachidonoyl lysophosphatidic acid in Alzheimer’s disease

Endocannabinoids: A unique opportunity to develop multitarget analgesics

Pal Pacher, Ph.D.

*Ph.D. in Cardiovascular Pharmacology from Semmelweis University

*Tenured Senior Investigator, National Institutes of Health


Interplay of liver-heart inflammatory axis and cannabinoid 2 receptor signaling in an experimental model of hepatic cardiomyopathy.

Disruption of Renal Arginine Metabolism Promotes Kidney Injury in Hepatorenal Syndrome in Mice.

Cardiovascular effects of marijuana and synthetic cannabinoids: the good, the bad, and the ugly

PARP inhibition protects against alcoholic and non-alcoholic steatohepatitis.

Poly (ADP-ribose) polymerase-1 is a key mediator of liver inflammation and fibrosis.

Monoacylglycerol lipase controls endocannabinoid and eicosanoid signaling and hepatic injury in mice.

A new cannabinoid CB2 receptor agonist HU-910 attenuates oxidative stress, inflammation and cell death associated with hepatic ischaemia/reperfusion injury.

Cannabinoid 1 receptor promotes cardiac dysfunction, oxidative stress, inflammation, and fibrosis in diabetic cardiomyopathy.

Is lipid signaling through cannabinoid 2 receptors part of a protective system?

Cannabidiol attenuates cardiac dysfunction, oxidative stress, fibrosis, and inflammatory and cell death signaling pathways in diabetic cardiomyopathy.

Cannabinoid-2 receptor limits inflammation, oxidative/nitrosative stress, and cell death in nephropathy.

Adenosine receptors: therapeutic aspects for inflammatory and immune diseases.

Measurement of cardiac function using pressure-volume conductance catheter technique in mice and rats.

Cannabinoids mediate analgesia largely via peripheral type 1 cannabinoid receptors in nociceptors.

Nitric oxide and peroxynitrite in health and disease.

Pharmacological inhibition of CB1 cannabinoid receptor protects against doxorubicin-induced cardiotoxicity.

Simultaneous detection of apoptosis and mitochondrial superoxide production in live cells by flow cytometry and confocal microscopy.

NO-independent stimulators and activators of soluble guanylate cyclase: discovery and therapeutic potential.

The endocannabinoid system as an emerging target of pharmacotherapy.

Therapeutic effects of xanthine oxidase inhibitors: renaissance half a century after the discovery of allopurinol.

Endocannabinoid activation at hepatic CB1 receptors stimulates fatty acid synthesis and contributes to diet-induced obesity.

Cannabinoids cool the intestine.

Ziva Cooper, Ph.D.

*Ph.D. in Biopsychology from the University of Michigan

*Director of the UCLA Center for Cannabis and Cannabinoids


Impact of co-administration of oxycodone and smoked cannabis on analgesia and abuse liability

Methodology for controlled administration of smoked synthetic cannabinoids JWH-018 and JWH-073

Sex-Dependent Effects of Cannabis and Cannabinoids: A Translational Perspective

Effects of ibudilast on oxycodone-induced analgesia and subjective effects in opioid-dependent volunteers

The Health Effects of Cannabis and Cannabinoids: The Current State of Evidence and Recommendations for Research

Effects of zolpidem alone and in combination with nabilone on cannabis withdrawal and a laboratory model of relapse in cannabis users.

Oral Cannabidiol does not Alter the Subjective, Reinforcing or Cardiovascular Effects of Smoked Cannabis.

Adverse Effects of Synthetic Cannabinoids: Management of Acute Toxicity and Withdrawal

Novel Pharmacologic Approaches to Treating Cannabis Use Disorder

Investigation of sex-dependent effects of cannabis in daily cannabis smokers

A human laboratory study investigating the effects of quetiapine on marijuana withdrawal and relapse in daily marijuana smokers

Effects of acute oral naltrexone on the subjective and physiological effects of oral D-amphetamine and smoked cocaine in cocaine abusers.

Comparison of a drug versus money and drug versus drug self-administration choice procedure with oxycodone and morphine in opioid addicts.

Comparison of the analgesic effects of dronabinol and smoked marijuana in daily marijuana smokers

Subjective, cognitive and cardiovascular dose-effect profile of nabilone and dronabinol in marijuana smokers.

Buprenorphine/naloxone as a promising therapeutic option for opioid abusing patients with chronic pain: reduction of pain, opioid withdrawal symptoms, and abuse liability of oral oxycodone.

Marijuana’s dose-dependent effects in daily marijuana smokers.

Nabilone decreases marijuana withdrawal and a laboratory measure of marijuana relapse.

Predictors of marijuana relapse in the human laboratory: robust impact of tobacco cigarette smoking status.

Effects of menstrual cycle phase on cocaine self-administration in rhesus macaques.

Glial modulators: a novel pharmacological approach to altering the behavioral effects of abused substances

Effects of baclofen and mirtazapine on a laboratory model of marijuana withdrawal and relapse.

Opioid antagonism enhances marijuana’s effects in heavy marijuana smokers.

Comparison of subjective, pharmacokinetic, and physiological effects of marijuana smoked as joints and blunts

Actions of delta-9-tetrahydrocannabinol in cannabis: relation to use, abuse, dependence.

Cannabis reinforcement and dependence: role of the cannabinoid CB1 receptor.

Naltrexone Maintenance Decreases Cannabis Self-Administration and Subjective Effects in Daily Cannabis Smokers.

Sex-dependent effects of cannabis-induced analgesia

Carrie Cuttler, Ph.D.

*Ph.D. in Cognitive Science from the University of British Columbia


Blunted stress reactivity in chronic cannabis users

Psychometric properties of the Daily Sessions, Frequency, Age of Onset, and Quantity of Cannabis Use Inventory (DFAQ-CU)

Symptoms of obsessive-compulsive disorder predict cannabis misuse

A cross-sectional survey of medical cannabis users: Patterns of use and perceived efficacy

Sex differences in cannabis use and effects: A cross-sectional survey of cannabis users

Mechanisms underlying the link between cannabis use and prospective memory

Jerry King, Ph.D. (The King of Cannabis Extraction)

*Ph.D. in Analytical Chemistry from Northeastern University

*Cannabis R&D expert

Riley Kirk, Ph.D.

*Ph.D. in Pharmaceutical Sciences from University of Rhode Island
*Cannabis educator and research scientist


Screening the PRISM Library against Staphylococcus aureus Reveals a Sesquiterpene Lactone from Liriodendron tulipifera with Inhibitory Activity

New Micropeptins with Anti-Neuroinflammatory Activity Isolated from a Cyanobacterial Bloom

Polyphenol Microbial Metabolites Exhibit Gut and Blood–Brain Barrier Permeability and Protect Murine Microglia against LPS-Induced Inflammation

Michelle Glass, Ph.D.

University of Octago profile:

*Head of the Department of Pharmacology & Toxicology at the University of Otago.


Cannabinoid receptors in the human brain: a detailed anatomical and quantitative autoradiographic study in the fetal, neonatal and adult human brain

Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors augments cAMP accumulation in striatal neurons: evidence for a Gs linkage to the CB1 receptor

Immunomodulation by cannabinoids is absent in mice deficient for the cannabinoid CB2 receptor.

The pattern of neurodegeneration in Huntington’s disease: a comparative study of cannabinoid, dopamine, adenosine and GABAA receptor alterations in the human basal ganglia in Huntington’s disease

Cannabinoid receptors and their endogenous agonists

Concurrent stimulation of cannabinoid CB1 and dopamine D2 receptors enhances heterodimer formation: a mechanism for receptor crosstalk?

Synthetic cannabis: adverse events reported to the New Zealand Pharmacovigilance Centre

Receptor alterations in human neuro-degenerative diseases

Nephi Stella, Ph.D.

*Ph.D. in Molecular Pharmacology and Ph.D. in Molecular Physiology from College de France

*Cannabinoid-based drug researcher


ABHD6 inhibition rescues a sex-dependent deficit in motor coordination in the HdhQ200/200 mouse model of Huntington’s disease

ATPS-15 Cannabidiol Reduces Glioma Cells Proliferation and Viability

ATPS-06-Brain-Penetrant Alkylindole Compounds Promote Apoptosis in Glioma Cells Through Microtubule Destabilization

The serine hydrolase ABHD6 controls the accumulation and efficacy of 2-AG at cannabinoid receptors

Cannabinoid receptors and endocannabinoids: Evidence for new players

Voluntary oral consumption of Δ9-tetrahydrocannabinol by adolescent rats impairs reward-predictive cue behaviors in adulthood

Dual Inhibition of α/β-Hydrolase Domain 6 and Fatty Acid Amide Hydrolase Increases Endocannabinoid Levels in Neurons

Measuring Endocannabinoid Hydrolysis: Refining our Tools and Understanding

Identification of α,β-Hydrolase Domain Containing Protein 6 as a Diacylglycerol Lipase in Neuro-2a Cells

Targeting Astrocytomas and Invading Immune Cells with Cannabinoids: A Promising Therapeutic Avenue

Endocannabinoid signaling and the deteriorating brain

Potential Upstream Regulators of Cannabinoid Receptor 1 Signaling in Prostate Cancer: A Bayesian Network Analysis of Data From a Tissue Microarray

Cannabis use by individuals with multiple sclerosis: effects on specific immune parameters

Differential migratory properties of monocytes isolated from human subjects naïve and non-naïve to Cannabis

Amber Wise, Ph.D.

*Ph.D. in Chemistry from the University of California at Berkeley

*Cannabis compliance and analytical testing expert


Metals in Cannabis Vaporizer Aerosols: Sources, Possible Mechanisms, and Exposure Profiles

Strategies for Nonpolar Aerosol Collection and Heavy Metals Analysis of Inhaled Cannabis Products

Deeper Dive into Extractions: Multiphase CO2 Extractions for Full Spectrum Native Chemical Profiles

Understanding the Science of Cannabis Produce Development

Extraction Basics, Scientifically Speaking

Upstream adverse effects in risk assessment: A model of polychlorinated biphenyls, thyroid hormone disruption and neurological outcomes in humans.

Are Oral Contraceptives Significant Contributors to Estrogenicity of Drinking Water?

Discrete Arrays of Liquid Crystal-Supported Proteolipid Monolayers as Phantom Cell Surfaces

Policy Recommendations for Addressing Potential Health Risks from Nanomaterials in California

Kevin Spellman, Ph.D.

*Ph.D. in Molecular Biology from University of Exeter, University of North Carolina

*Cannabinoid and cannabis phytochemical expert


Neurological Activity of Lion’s Mane (Hericium erinaceus)

The identification of a novel SIRT6 modulator from Trigonella foenum-graecum using ligand fishing with protein coated magnetic beads

Clinical Utility of Curcumin Extract 19(2):14-6

Cannabinoid-Opioid Interaction in Chronic Pain.

Detection, characterization, and screening of heme-binding molecules by mass spectrometry for malaria drug discovery

A review of medicinal plants that modulate nitric oxide activity.

The traditional medicine Spilanthes acmella, and the alkylamides spilanthol and undeca-2E-ene-8,10-diynoic acid isobutylamide, demonstrate in vitro and in vivo anti-malarial activity.

The antiplasmodium effects of a traditional South American remedy: Zanthoxylum chiloperone var. Angustifolium against chloroquine resistant and chloroquine sensitive strains of Plasmodium falciparum

Traditional herbal remedies that influence cell adhesion molecule activity.

Development and characterization of immobilized cannabinoid receptor (CB1/CB2) open tubular column for on-line screening.

The influence of bitter, aromatic and pungent medicinal plants on gut function.

Ecological Pharmacy: From Gaia to Pharmacology.

The influence of traditional herbal formulas on cytokine activity

Comparison of alkylamide yield in ethanolic extracts prepared from fresh versus dry Echinacea purpurea utilizing HPLC-ESI-MS

Role for PPARγ in IL-2 inhibition in T cells by Echinacea derived undeca-2E-ene-8,10-diynoic acid isobutylamide

The diuretic effect in human subjects of an extract of Taraxacum officinale folium over a single day

A critical evaluation of drug interactions with Echinacea spp.

Types of Interactions of Plant Metabolites –Synergistic Modes of Interactions

Liver enzyme-mediated oxidation of Echinacea purpurea alkylamides: production of novel metabolites and changes in immunomodulatory activity.

Modulation of cytokine expression by traditional medicines: a review of herbal immunomodulators

Philosophy in Phytopharmacology: Ockham’s Razor versus synergy

National policy dialogue to advance integrated health care: Finding common ground-Final report to the Whitehouse

Folate and vitamin B12 status of adolescent girls in northern Nigeria

Shimon Lecht, Ph.D.

*Ph.D. in Pharmacology from the Hebrew University of Jerusalem

*Member, Committee D37 on Cannabis Standards – ASTM International

*Cannabis-based drug R&D expert

Dr. Lecht has authored or co-authored more than 50 publications, which can be viewed here:

Is there a cannabis scientist missing from this list? Let us know – you can use our CONTACT FORM, or you can message the author via LinkedIn:

Russ Hudson is an international cannabis consultant and author of The Big Book of Terps – the world’s largest resource on terpenes, flavonoids, and synergy in cannabis. Russ has dedicated more than 30 years to cannabis, working with the private social clubs of Spain, and the coffeeshops and suppliers of the Netherlands, while also specializing as a cannabis licensing and regulatory expert in more than a dozen US states. Russ has been arrested and jailed for cultivation and trafficking, he has been the subject of a Vice documentary, he has written a children’s book about cannabis, and he currently researches and collaborates with the world’s leading cannabinoid, terpene, and flavonoid scientists.


    • Honey Smith Walls

    • 4 months ago

    Did I miss Dr. Bonnie Goldstein? Her work in autism is legendary. Thank you for this list. Saw many of my tribe on here. Proud of the hard work all these greats in cannabis have done.

    • David Watson

    • 3 months ago

    We all stand on the shoulders of giants.

Leave a Reply

Your email address will not be published. Required fields are marked *